Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial

Abstract

This clinicopathological study shows that anti-E-selectin (CDP850), although a well-tolerated, logical and safe therapy, does not appear to possess a therapeutic role in the treatment of chronic plaque psoriasis.